Last reviewed · How we verify
Hair Sample
At a glance
| Generic name | Hair Sample |
|---|---|
| Sponsor | Shalvata Mental Health Center |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
- Headache
- SARS-CoV-2 test positive
- Nasopharyngitis
- Upper respiratory tract infection
- Acne
- COVID-19
- Pyrexia
- Cough
- Fatigue
- Urticaria
- Oropharyngeal pain
- Urinary tract infection
Key clinical trials
- Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment (NA)
- Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
- Cortical Electrophysiology of Response Inhibition in Parkinson's Disease (PHASE4)
- Neuromodulation With Percutaneous Electrical Nerve Field Stimulation (NA)
- Study to Evaluate Xtresse Serum in Individuals With Thinning Hair (NA)
- Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists (NA)
- Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment
- GENESIS Project: Generating Evidence on the Needs of Ecuadorian Adolescents
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hair Sample CI brief — competitive landscape report
- Hair Sample updates RSS · CI watch RSS
- Shalvata Mental Health Center portfolio CI